GiovanBattista Leoni

Combined therapy with deferiprone and desferrioxamine in thalassemia major.

Raffaella Origa, Patrizio Bina, Annalisa Agus et al. · PubMed · 2005 · 145 citations

Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major.

Renzo Galanello, Antonio Piga, Gian Luca Forni et al. · PubMed · 2006 · 139 citations

A prospective randomized controlled trial on the safety and efficacy of alternating deferoxamine and deferiprone in the treatment of iron overload in patients with thalassemia.

Renzo Galanello, Antonis Kattamis, Antonio Piga et al. · PubMed · 2006 · 80 citations

Adverse Events, Alternating Therapy, Iron Metabolism +9

Impact of heart magnetic resonance imaging on chelation choices, compliance with treatment and risk of heart disease in patients with thalassaemia major

Raffaella Origa, Fabrice Danjou, S. Cossa et al. · British Journal of Haematology · 2013 · 37 citations

Quality of life in Sardinian patients with transfusion-dependent Thalassemia: a cross-sectional study

Francesca Floris, Federica Comitini, GiovanBattista Leoni et al. · Quality of Life Research · 2018 · 25 citations

Quality Of Life, Transfusion Medicine, Hematology +8